Skip to content

About / Media Center

Trinity Press Releases

Filter by Type:
May 2, 2024

Trinity Life Sciences Launches the Only Predictive Insights Solution Powered by AI/ML and Grounded in Market Research and Real-World Data

Waltham, MA, May 1, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched a new solution that accurately predicts stakeholder behavior providing deeper insights. For the first time, life sciences companies can incorporate real-world, healthcare...
Read the Press Release
April 3, 2024

Trinity Life Sciences Unveils Industry Impact Series to Support Life Sciences Executives on Critical Decision Making

Waltham, MA, April 3, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, unveils its Industry Impact Series—a thought leadership series designed to identify key issues that will revolutionize the way therapeutics are developed and commercialized in the years...
Read the Press Release
March 26, 2024

Trinity Life Sciences Reveals Six Key Global Market Access Trends That Life Sciences Companies Need to Be Monitoring

An Upcoming Webinar Entitled “Annual State of Global Market Access” Will Review Findings Waltham, MA, March 26, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Annual State of Global Market Access white paper,...
Read the Press Release
February 28, 2024

Trinity Life Sciences Launches Brand Insights AI

Waltham, MA, February 28, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts with deep...
Read the Press Release
February 13, 2024

Trinity Life Sciences Evaluates Commercial Performance Over 3 Years of 58 Novel Drugs Approved in 2020

Waltham, MA, February 13, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Trinity Annual Drug Index white paper, an evaluation of the commercial performances over three years of 58 novel drugs...
Read the Press Release
December 20, 2023

China’s 2022 NRDL Update Demonstrates Promising Pricing and Access Opportunities for Innovative Drugs With Significant Clinical Benefit

Waltham, MA, December 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that China’s 2022 National Reimbursement Drug List (NRDL) demonstrates promising pricing and access opportunities for innovative drugs with significant clinical benefit. The new...
Read the Press Release
December 18, 2023

Trinity Life Sciences Institutes a Formal Cell and Gene Therapy Center of Excellence

New White Paper “Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology” Delivers Overarching Assessment of the Natural Killer Cell Therapy Space Waltham, MA, December 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization...
Read the Press Release
December 13, 2023

New Advisory Brief Reveals What Life Sciences Companies Need to Know Now to Be Prepared for 2024

Waltham, MA, December 13, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared for 2024” based on highlights presented at the...
Read the Press Release
November 29, 2023

Pfizer’s Nurtec Receives Top Ranking in 2023 TGaS Digital Marketing Competency Report

Waltham, MA, November 29, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates...
Read the Press Release
November 20, 2023

Trinity Life Sciences Maps Out Investment Strategies and Tactics to Calibrate a Patient-Centric Approach in Rare Disease

Waltham, MA, November 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief outlines four pillars...
Read the Press Release
October 23, 2023

Trinity Life Sciences Names First Chief Technology Officer

Waltham, MA, October 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building...
Read the Press Release
October 11, 2023

Trinity Life Sciences Uses New “Tethered” Approach to Integrate HCP-Level Real-World Data and Improve Brand Share Estimates

Waltham, MA, October 11, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces the first method that incorporates Healthcare Professionals (HCP)-specific real-world behaviors to improve share calibration for forecasting.  The method, called “tethering,” uses real-world prescribing...
Read the Press Release
Back To Top